Pharmaceutical Tech

Apr102016 by Pharmaceutical TechNo Comments

What Can Recent Mergers Mean for the Future of Pharmaceutical Industry?

Expensive pharmaceutical deals in the industry are in a mad fury of alliances this year on account of the patent expiries that big drug companies are faced with. In an attempt to make up for the losses, hence, these companies are teaming up with their better off competitors. The world’s most well-known drug maker, Pfizer and London’s AstraZeneca have been heard to contemplate joining hands in a potential $100 billion epic merger which is a sign that the pharmaceutical sector is brimming with many more such deals in the days to come. Mergermarket, the famous research firm, shows data that suggest that five pharmacy deals valuing more than $2 billion in the first four months of 2014 are of the same momentum possibly, like seven deals of the same value that were announced in the entire year...

Apr72016 by Pharmaceutical TechNo Comments

Low-Cost Genome Sequencing

BioPharma, Biotechnology, Cheminformatics, Drug Development, Drug Discovery, Economic and Regional Development, Pharma Industry

In Silicon Valley, Moore's law appears to remained on equivalent balance with the regular laws classified by Isaac Newton. Intel prime supporter Gordon Moore's notorious perception that registering power has a tendency to twofold — and that its value hence parts — like clockwork has held valid for about 50 years with just minor update. Yet as a model of quick transform, it is the focus of energetic ill-use from genome analysts. In many presentations over the past few years, researchers have contrasted the slant of Moore's law and the quickly dropping expenses of DNA sequencing. For some time they kept pace, however since something like 2007, it has not even been close. The cost of sequencing a normal human genome has plunged from about Us$10 million to a couple of thousand dollars in only...

Apr42016 by Pharmaceutical TechNo Comments

The Problems with Healthcare Data and How to Manage Them

Pharma Industry, Pharmacetiucal Infotech

People who work with data tend to think in terms which are very structured and linear. They prefer to have B to follow A and C to follow B not just sometimes, but pretty much all of the time. But, healthcare data simply doesn’t work that way. Healthcare data can render linear analysis useless as it is both diverse and complex. There are several characteristics of healthcare data which make it both unique and often difficult to work with. Let’s discuss just a few of those characteristics. Multiple Places Healthcare data tends to be found in a variety of different places. The data tends to come from all over an organisation, from EMRs or human resources software to varying departments such as oncology, radiology or pharmacy. Compiling all of this information into one single central syste...

Apr32016 by Pharmaceutical TechNo Comments

Why is Good Tablet Design so Important and How to Achieve it?

Combinatorial Chemistry, Drug Development, Pharmaceutical Chemicals and Intermediates, Pharmaceutical Excipients and Drug Formulation, Tableting and Encapsulation

Detailed design of pharmaceutical and nutraceutical tablets is essential in order to produce robust tablets with bespoke designs. Tablet manufacturers should not overlook tablet design because it is key to the quality of the end product. “With sufficient fore-thought and consideration, most potential tablet making problems can be eliminated at the early stage of design. ” I Holland. Good tablet design is extremely important; it has an impact upon anti-counterfeiting, tooling strength,tablet coating, durability and functionality. Good tablet design helps to avoid downstream manufacturing problems such as tablet sticking, picking, lamination, capping and premature tooling failures. It is essential to consider these at the beginning of the process, ensuring a problem free, high quality, end...

Mar312016 by Pharmaceutical TechNo Comments

Collaborations are a Secret Boon for the Pharma Industry in India

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development

After it was recently announced that Bristol-Meyes Squibb and Astra Zenca ended their partnership and Aurobindo Pharma would acquire Dublin-based Actavis, the question on everyone’s minds seems to be, what next? The pharma industry has seen a double-growth in recent times owing to breakthrough patents in the field of cancer drugs and research. Therapies which are closely linked to winter related ailments, have posted strong double digit growths (such as respiratory at over 18.7 per cent, pain or analgesics at over 10.1 per cent), resulting in acute therapies growing faster than chronic segment, for the second consecutive month. For the full year 2013, the pharmaceutical market was reported at Rs 78,644 crore, with a growth of 9.9 per cent, over the same period last year. The Indian mark...

Mar302016 by Pharmaceutical TechNo Comments

Is South Africa Trying to delay Patents on New Medicines?

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development, Pharmaceutical Distribution and Logistics, Pharmaceutical Patenting

In a recent report by the Guardian, it was revealed that leaked documents showed lobbying proposals to delay laws that would allow fast introduction of generic medicines in South Africa. Shockingly, this means patents on breakthrough (read recently discovered medicine) drugs could be halted, but for what? If the changes to the new intellectual property law take place, this could be a definite reality, warns the Guardian. Drug companies in South Africa have been accused of planning a covert, well-funded campaign to delay the introduction of laws that threaten their profits. Leaked documents show that pharmaceutical companies planned a $450,000 campaign, involving a high-profile consultancy based in Washington, DC, against changes to intellectual property laws that would enable their pat...

Mar272016 by Pharmaceutical TechNo Comments

Glenmark Gives India the Push by Topping its Anti-Diabetes Drug

Pharma Industry, Pharmaceutical Business Development, Pharmaceutical Collaboration

Whatever Glenmark wanted to prove by introducing Zitamed and ZIta, their new anti-diabetes drugs, they’ve definitely topped this season. Mumbai-based Glenmark Pharmaceuticals introduced the two anti-diabetes drugs in aRs 3,000-crore lucrative anti-diabetes market dominated by multinationals The drugmaker, which is locked in a bitter patent infringement battle with US drug firm Merck Sharp and Dohme's (MSD) over these drugs, has managed to rake in Rs 16 crore in just eight months since it launched them, according to data available with All India Organisation of Chemists and Association (AIOCD). In a sort of kickback, Glenmark has priced these drugs at a third of the price of its competitors. Win? We definitely think so. This move may not only rattle the existing market, but also multina...

Mar252016 by Pharmaceutical TechNo Comments

How Anti-Depressants Work to Help you Feel Better

Cure & Prevention, Specific Drugs

Depression is essentially a strange state of mental breakdown, gradual or rapid. Depression strikes some 35 million people worldwide, according to the World Health Organization, contributing to lowered quality of life as well as an increased risk of heart disease and suicide. Treatments typically include psychotherapy, support groups and education as well as psychiatric medications. The action of these compounds is fairly common. Certain anti-depressants increase available levels of serotonin, sometimes referred to as the feel-good neurotransmitter, in our brains. Neurons communicate via neurotransmitters, chemicals which pass from one nerve cell to another. A transporter molecule recycles unused transmitter and carries it back to the pre-synaptic cell. For serotonin, that shuttle is c...

Mar212016 by Pharmaceutical TechNo Comments

Weighing and Dispensing Process and Technology in Pharma Industries

Drug Development, Pharmaceutical Chemicals and Intermediates, Pharmaceutical Excipients and Drug Formulation, Pharmaceutical Instrumentation and Controls, Pharmaceutical Quality Assurance, Pharmaceutical Research and Development

Weighing and dispensing process in pharma industries occupies a high priority position. Over the last decades, increased regulations on the manufacturing processes in pharma manufacturing industries led the focus and result is the advanced technology and stringent policies and frameworks. The pharmaceutical companies can increase the speed and accuracy of their operations with weigh and dispense process technology. While, weighing and dispensing of solids and liquids is a very common activity throughout the pharmaceutical industry processes. Traditionally, workers dispense pharma materials by hand-scooping solids and pumping or pouring liquids. This is generally conducted in a warehouse during chemical production or in a pharmacy during pharmaceutical dosage-form manufacturing. The chanc...

Mar152016 by Pharmaceutical TechNo Comments

ICT an Aid to the Pharma Sector

Pharma Industry, Pharmacetiucal Infotech

Tremendous pressures exerted from every source for the societal and economic development keep exercising pressures from all around. Governments look forward for the companies from vivid industrial sectors to outperform and raise the scope for employment, GDP contribution and the revenues to the government in form to various taxes. At the same the companies are keen on huge investments in any state, only when the state is in a position of offer them good subsidies, and tax exemptions and infrastructure which can facilitate them with the logistics, human resource skill development, and the key issue of ICT facilitation. In today's scenario, many states are keen on encouraging the investments from pharma companies, and these locations have become a free zone for the companies of small and m...